[go: up one dir, main page]

HK1162031B - 作為bcl-2選擇性的凋亡誘導劑用於治療癌症和免疫性疾病的磺胺衍生物 - Google Patents

作為bcl-2選擇性的凋亡誘導劑用於治療癌症和免疫性疾病的磺胺衍生物 Download PDF

Info

Publication number
HK1162031B
HK1162031B HK12102482.7A HK12102482A HK1162031B HK 1162031 B HK1162031 B HK 1162031B HK 12102482 A HK12102482 A HK 12102482A HK 1162031 B HK1162031 B HK 1162031B
Authority
HK
Hong Kong
Prior art keywords
methyl
sulfonyl
piperazin
benzamide
yloxy
Prior art date
Application number
HK12102482.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1162031A1 (zh
Inventor
Milan Bruncko
Hong Ding
George A. Doherty
Steven W. Elmore
Lisa Hasvold
Laura Hexamer
Aaron R. Kunzer
Robert A. Mantei
William J. Mcclellan
Chang H. Park
Cheol-Min Park
Andrew M. Petros
Xiaohong Song
Andrew J. Souers
Gerard M. Sullivan
Zhi-Fu Tao
Gary T. Wang
Le Wang
Xilu Wang
Michael D. Wendt
Original Assignee
Abbvie Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc. filed Critical Abbvie Inc.
Priority claimed from PCT/US2009/066790 external-priority patent/WO2010065865A2/en
Publication of HK1162031A1 publication Critical patent/HK1162031A1/zh
Publication of HK1162031B publication Critical patent/HK1162031B/zh

Links

HK12102482.7A 2008-12-05 2009-12-04 作為bcl-2選擇性的凋亡誘導劑用於治療癌症和免疫性疾病的磺胺衍生物 HK1162031B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12027508P 2008-12-05 2008-12-05
US61/120,275 2008-12-05
US18118009P 2009-05-26 2009-05-26
US61/181,180 2009-05-26
PCT/US2009/066790 WO2010065865A2 (en) 2008-12-05 2009-12-04 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

Publications (2)

Publication Number Publication Date
HK1162031A1 HK1162031A1 (zh) 2012-08-17
HK1162031B true HK1162031B (zh) 2017-02-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP2376480B1 (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
EP2507229B1 (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
US8586754B2 (en) BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
EP2376197B1 (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
AU2013211540B2 (en) Sulfonamide derivatives as Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
HK1162031B (zh) 作為bcl-2選擇性的凋亡誘導劑用於治療癌症和免疫性疾病的磺胺衍生物
HK1230602A1 (zh) 作为用於治疗癌症和免疫疾病的bcl-2-选择性细胞凋亡诱导剂的磺酰胺衍生物
HK1177201B (zh) 治療癌症和免疫疾病的作為bcl-2-選擇性細胞凋亡誘導劑的磺酰胺衍生物
HK1231044A1 (zh) 用於治疗癌症以及免疫和自身免疫性疾病的凋亡诱导剂
HK1177202B (zh) 用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘導劑
HK1177202A1 (zh) 用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘導劑
HK1161993B (zh) 用於治療癌症以及免疫和自身免疫性疾病的凋亡誘導劑
HK1161993A (zh) 用於治療癌症以及免疫和自身免疫性疾病的凋亡誘導劑